Publication
Title
Management of patients with inflammatory bowel disease and spondyloarthritis
Author
Abstract
Introduction: More than half of the patients with inflammatory bowel disease (IBD) experience at least one extra-intestinal manifestation (EIM). The most common EIM in patients with IBD is spondyloarthritis (SpA). Microscopic intestinal inflammation is documented in almost 50% of the patients with SpA.Areas covered: We give an overview of the classification, the epidemiology and the diagnosis of IBD and SpA. The treatment goals, the pharmacologic management options and the available treatment guidelines in IBD patients with SpA are discussed.Expert commentary: The coexistence of IBD and SpA generates challenges and opportunities for both the gastroenterologist and the rheumatologist. The potential of drugs with a gut-specific mode of action in the treatment of IBD-related arthritis warrants further exploration.
Language
English
Source (journal)
Expert review of clinical pharmacology
Publication
Abingdon : Taylor & francis ltd , 2017
ISSN
1751-2433
1751-2441
DOI
10.1080/17512433.2017.1377609
Volume/pages
10 :12 (2017) , p. 1363-1374
ISI
000418037400007
Pubmed ID
28879780
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 08.02.2018
Last edited 09.10.2023
To cite this reference